Incontinence in the frail elderly: Report from the 4th international consultation on incontinence

Neurourology and Urodynamics

Volumn 29, Issue 1, 2010, Pages 165-178

  DuBeau, Catherine E ^a   Kuchel, George A ^b   Johnson II, Theodore ^c   Palmer, Mary H ^d   Wagg, Adrian ^e  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Frail elderly; Incontinence; Nocturia; Urinary retention

Indexed keywords

DARIFENACIN; OXYBUTYNIN; PLACEBO; SOLIFENACIN; TOLTERODINE;

AGING; BEHAVIOR THERAPY; CAREGIVER; CLINICAL TRIAL; COMORBIDITY; CONSULTATION; DEATH; DRUG DOSE TITRATION; ENDURANCE; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; FRAIL ELDERLY; HOME CARE; HUMAN; LIFESTYLE MODIFICATION; LONG TERM CARE; MEDICAL STAFF; MUSCLE STRENGTH; NOCTURIA; NUTRITION; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PHENOTYPE; PHYSICAL ACTIVITY; PHYSIOLOGY; REVIEW; SYSTEMATIC REVIEW; TACHYCARDIA; URINE INCONTINENCE; URINE RETENTION;

AGED; AGED, 80 AND OVER; ALGORITHMS; BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; FRAIL ELDERLY; HUMANS; INTERNATIONAL COOPERATION; ORGANIZATIONS; RISK FACTORS; URINARY INCONTINENCE; UROLOGY;

EID: 76049092251     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20842     Document Type: Review

References (115)

1. Ferrucci L, Guralnik JM, Studenski S, et al. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: A consensus report. J Am Geriatr Soc 2004;52:625-34.
2. Holroyd-Leduc JM, Mehta KM, Covinsky KE. Urinary incontinence and its association with death, nursing home admission, and functional decline. J Am Geriatr Soc 2004;52:712-8.
3. Morrison A, Levy R. Fraction of nursing home admissions attributable to urinary incontinence. Value Health 2006;9:272-4.
4. Boyington J, Howard D, Carter-Edwards L, et al. Differences in resident characteristics and prevalence of urinary incontinence in nursing homes in the southeastern United States. Nurs Res 2007;56:97-107.
5. Baztan JJ, Arias E, Gonzalez N, et al. New-onset urinary incontinence and rehabilitation outcomes in frail older patients. Age Ageing 2005;34:172-5.
6. Inouye SK, Studenski S, Tinetti ME, et al. Geriatric syndromes: Clinical, research, and policy implications of a core geriatric concept. J AmGeriatr Soc 2007;55:780-91.
7. DuBeau CE. Beyond the bladder: Management of urinary incontinence in older women. Clin Obstet Gynecol 2007;50:720-34.
8. Tadic SD, Griffiths D, Schaefer W, et al. Abnormal connections in the supraspinal bladder control network in women with urge urinary incontinence. Neuroimaging 2008;39:1647-53.
9. Kuchel G, Moscufo N, Guttmann C, et al. Localization of brain white matter hyperintensities and urinary incontinence in community-dwelling older adults. J Gerontol Med Sci 2009 (in press).
10. Griffiths D, Derbyshire S, Stenger A, et al. Brain control of normal and overactive bladder. J Urol 2005;174:1862-7.
11. Pfisterer MH, Griffiths DJ, Schaefer W, et al. The effect of age on lower urinary tract function: A study in women. J AmGeriatr Soc 2006;54:405-12.
12. Taylor JA III, Kuchel GA. Detrusor underactivity: Clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr Soc 2006;54:1920-32.
13. Trowbridge E, Wei J, Fenner D, et al. Effects of aging on lower urinary tract and pelvic floor function in nulliparous women. Obstet Gynecol 2007;109:715-20.
14. Kenton K, Lowenstein L, Simmons J, et al. Aging and overactive bladder may be associated with loss of urethral sensation in women. Neurourol Urodyn 2007;26:981-4.
15. Yang J, Yang S, Huang W. Functional correlates of Doppler flow study of the female urethral vasculature. Ultrasound Obstet Gynecol 2006;28:96-102.
16. Siracusano S, Bertolotto M, Cucchi A, et al. Application of ultrasound contrast agents for the characterization of female urethral vascularization in healthy pre- and postmenopausal volunteers. Eur Urol 2006;50:1316-22.
17. Clobes A, DeLancey J, Morgan D. Urethral circular smooth muscle in young and old women. J Obstet Gynecol 2008;198:587e1-5.
18. Lawrence J, Lukacz E, Nager C, et al. Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol 2008;111:678-85.
19. Tan J, Lukacz E,Menefee S, et al. Determinants of vaginal length. AmJ Obstet Gynecol 2006;195:1846-50.
20. Juthani-Mehta M, Tinetti M, Perrelli E, et al. Diagnostic accuracy of criteria for urinary tract infection in a cohort of nursing home residents. J Am Geriatr Soc 2007;55:1072-7.
21. Kramer G, Mitteregger D, Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 2007;51:1202-16.
22. Mishra V, Allen D, Nicolaou C, et al. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int 2007;100:327-31.
23. Cigolle CT, Langa KM, Kabeto MU, et al. Geriatric conditions and disability: The Health and Retirement Study. Ann Intern Med 2007;147:156-64.
24. Rait G, Fletcher A, Smeeth L, et al. Prevalence of cognitive impairment: Results from the MRC trial of assessment and management of older people in the community. Age Ageing 2005;34:242-8.
25. Huang A, Brown J, Thom D, et al. Study of Osteoporotic Fractures Research Group. Urinary incontinence in older community-dwelling women: The role of cognitive and physical function decline. Obstet Gynecol 2007;109:909-16.
26. Wullner U, Schmitz-Hubsch T, Antony G, et al. Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): The effect of ageing. Eur J Neurol 2007;14:1405-8.
27. Balash Y, Peretz C, Leibovich G, et al. Falls in outpatients with Parkinson's disease. J Neurol 2005;252:1310-5.
28. Fultz NH, Rahrig Jenkins K, Østbye T, et al. The impact of own and spouse's urinary incontinence on depressive symptoms. Soc Sci Med 2005;60:2537-48.
29. Yoshida Y, Kim H, Iwasa H, et al. Prevalence and characteristics of urinary incontinence in community-dwelling-elderly as determined by comprehensive health examination and interview for the prevention of geriatric syndrome and bed-ridden state. Nippon Ronen Igakkai Zasshi 2007;44:83-9.
30. Song H, Bae J. Prevalence of urinary incontinence and lower urinary tract symptoms for community-dwelling elderly 85 years of age and older. J Wound Ostomy Continence Nurs 2007;34:535-41.
31. Ko Y, Lin S, Salmon J, et al. The impact of urinary incontinence on quality of life of the elderly. Am J Manag Care 2005;11:S103-11.
32. Ruby C, et al. Medication use and control of urination among communitydwelling older adults. J Aging Health 2005;17:661-74.
33. Nelson RL, Furner SE. Risk factors for the development of fecal and urinary incontinence in Wisconsin nursing home residents. Maturitas 2005;52:26-31.
34. Takazawa K, Arisawa K. Relationship between the type of urinary incontinence and falls among frail elderly women in Japan. J Med Invest 2005;52:165-71.
35. Chen JS, March LM, Schwarz J, et al. A multivariate regression model predicted falls in residents living in intermediate hostel care. J Clin Epidemiol 2005;58:503-8.
36. Woodford H, George J. NICE guidelines on urinary incontinence in women. Age Ageing 2007;36:349-50.
37. DuBeau CE, Ouslander JG, Palmer MH. Knowledge and attitudes of nursing home staff and surveyors about the revised federal guidance for incontinence care. Gerontologist 2007;47:468-79.
38. Fung C, Spencer B, Eslami M, et al. Quality indicators for the screening and care of urinary incontinence in vulnerable elders. J Am Geriatr Soc 2007;55:S443-9.
39. Wagg A, Potter J, Peel P, et al. National audit of continence care for older people: Management of urinary incontinence. Age Ageing 2008;37:39-44.
40. Saliba S, Elliott M, Rubenstein L, et al. The Vulnerable Elders Survey (VES-13): A tool for identifying vulnerable elders in the community. J Am Geriatr Soc 2001;49:1691-9.
41. Holroyd-Leduc J, Tannenbaum C, Thorpe K, et al. What type of urinary incontinence does this woman have? J Am Med Assoc 2008;299:1446-56.
42. Cai L, Lubitz J. Was there compression of disability for older Americans from 1992 to 2003? Demography 2007;44:479-95.
43. Pfisterer MH, Johnson TM II, Jenetzky E, et al. Geriatric patients' preferences for treatment of urinary incontinence: A study of hospitalized, cognitively competent adults aged 80 and older. J Am Geriatr Soc 2007;55:2016-22.
44. DuBeau C, Simon S, Morris J. Impact of urinary incontinence on quality of life in nursing home residents. J Am Geriatr Soc 2006; 54:1325-33.
45. Fonda D, Abrams P. Cure sometimes, help always-A "continence paradigm" for all ages and conditions. Neurourol Urodyn 2006;25:290-2.
46. Anger J, Saigal C, Madison R, et al. Increasing costs of urinary incontinence among female Medicare beneficiaries. J Urol 2006;176:247-51.
47. Reeves P, Irwin D, Kelleher C, et al. The current and future burden and cost of overactive bladder in five European countries. Eur Urol 2006;50:1050-7.
48. Darkow T, Fontes C, Williamson T. Costs associated with the management of overactive bladder and related comorbidities. Pharmacotherapy 2005;25:511-9.
49. Morris AR, Ho MT, Lapsley H, et al. Costs of managing urinary and faecal incontinence in a sub-acute care facility: A "bottom-up" approach. Neurourol Urodyn 2005;24:56-62.
50. Wodchis WP, Teare GF, Anderson GM. Cost and quality: Evidence from Ontario long term care hospitals. Med Care 2007;45:981-8.
51. Landefeld CS, Bowers BJ, Feld AD, et al. National Institutes of Health state-ofthe-science conference statement: Prevention of fecal and urinary incontinence in adults. Ann Intern Med 2008;148:449-58.
52. Langa KM, Fultz NH, Saint S, et al. Informal caregiving time and costs for urinary incontinence in older individuals in the United States. J Am Geriatr Soc 2002;50:733-7.
53. LarocheM-L, Charmes J-P, Nouaille Y, et al. Is inappropriatemedication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007;63:177-86.
54. Starr J. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease. J Am Geriatr Soc 2007;55:800-1.
55. Siegler EL, Reidenberg M. Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia. Clin Pharmacol Ther 2004;75:484-8.
56. Sink K, Thomas J III, Xu H, et al. Dual use of bladder anticholinergics and cholinesterase inhibitors: Long-term functional and cognitive outcomes. J Am Geriatr Soc 2008;56:847-53.
57. Teunissen TA, de Jonge A, van Weel C, et al. Treating urinary incontinence in the elderly-Conservative therapies that work: A systematic review. J Fam Pract 2004;53:25-30, 2.
58. van Houten P, Achterberg W, Ribbe M. Urinary incontinence in disabled elderly women: A randomized clinical trial on the effect of trainingmobility and toileting skills to achieve independent toileting. Gerontology 2007;53:205-10.
59. Dingwall L, McLafferty E. Do nurses promote urinary continence in hospitalized older people? An exploratory study. J Clin Nurs 2006;15:1276-86.
60. Ostaszkiewicz J. A clinical nursing leadership model for enhancing continence care for older adults in a subacute inpatient care setting. J Wound Ostomy Continence Nurs 2006;33:624-9.
61. Narayanan S, Cerulli A, Kahler K, et al. Is drug therapy for urinary incontinence used optimally in long-term care facilities? J Am Med Dir Assoc 2007;8:98-104.
62. Minassian V, et al. Randomized trial of oxybutynin extended versus immediate release for women aged 65 and older with overactive bladder; lessons learned from conducting a trial. J Obstet Gynaecol Can 2007;29:726-32.
63. Lackner T, Wyman J, McCarthy T, et al. Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence. J Am Geriatr Soc 2008;56:862-70.
64. Sand P, et al. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: A multi-centre community based, randomized study. BJU Int 2007;99:836-44.
65. Nitti V, et al. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol 2007;178:2488-94.
66. Krauwinkel W, Smulders R, Mulder H, et al. Effect of age on the pharmacokinetics of solifenacin in men and women. Int J Clin Pharmacol Ther 2005;43:227-38.
67. Wagg A, Wyndaele J, Sieber P. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: A pooled analysis. Am J Geriatr Pharmacother 2006;4:14-24.
68. Michel M, Wetterauer U, Vogel M, Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: A 12-week, open-label, post-marketing surveillance study. Drug Saf 2008;31:505-14.
69. Chapple C, DuBeau C, Ebinger U, et al. Darifenacin treatment of patients > or = 65 years with overactive bladder: Results of a randomized, controlled, 12-week trial. Curr Med Res Opin 2007;23:2347-58.
70. Lipton R, Kolodner K, Wesnes K. Assessment of cognitive function of the elderly population: Effects of darifenacin. J Urol 2005;173:493-8.
71. Kay G, et al. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol 2006;50:317-26.
72. Dmochowski R, Sand P, Zinner N, et al. Trospium 60 mg once daily (QD) for overactive bladder syndrome: Results from a placebo-controlled interventional study. Urology 2008;71:449-54.
73. Solomon DH, LoCicero L, Rosenthal RA, (eds). New Frontiers in Geriatrics Research: An Agenda for Surgical and Related Medical Specialties. New York: American Geriatrics Society; 2001.
74. Griebling T. Geriatric urology. In: Solomon DH, LoCicero L, Rosenthal R, editors. New Frontiers in Geriatric Research. New York: American Geriatrics Society; 2004. p 269-302.
75. Miller K, Stenchever M, Richter H, et al. Geriatric gynecology. In: Solomon D, LoCicero L, Rosenthal R, editors. New Frontiers in Geriatrics Research: An Agenda for Surgical and Related Medical Specialties. New York: American Geriatrics Society; 2004. p 225-67.
76. LoCicero J, Bierman AS, Coleman AL, et al. New Frontiers in Geriatrics Research: An Agenda for Surgical and Related Medical Specialties. Supplement New York, American Geriatrics Society, 2004, pp 369-419.
77. Boyles SH, Weber AM, Meyn L. Ambulatory procedures for urinary incontinence in the United States, 1994-1996. Am J Obstet Gynecol 2004;190:33-6.
78. Brown JS, Waetjen LE, Subak LL, et al. Pelvic organ prolapse surgery in the United States, 1997. Am J Obstet Gynecol 2002;186:712-6.
79. Campeau L, Tu L, Lemieux M, et al. A multicenter, prospective, randomized clinical trial comparing tension-free vaginal tape surgery and no treatment for the management of stress urinary incontinence in elderly women. Neurourol Urodyn 2007;26:990-4.
80. Dalpiaz O, Primus G, Schips L. SPARC sling system for treatment of female stress urinary incontinence in the elderly. Eur Urol 2006;50:826-31.
81. Rosow C, Gomery P, Chen T, et al. Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone. Clin Pharmacol Ther 2007;82:48-53.
82. Pfisterer MH, Griffiths DJ, Rosenberg L, et al. The impact of detrusor overactivity on bladder function in younger and older women. J Urol 2006; 175:1777-83.
83. Gehrich A, Stany M, Fischer J, et al. Establishing a mean postvoid residual volume in asymptomatic perimenopausal and postmenopausal women. Obstet Gynecol 2007;110:827-32.
84. Wu J, Baguley I. Urinary retention in a general rehabilitation unit: Prevalence, clinical outcome, and the role of screening. Arch Phys Med Rehabil 2005;86:1772-7.
85. Lukacz E, DuHamel E, Menefee S, et al. Elevated postvoid residual in women with pelvic floor disorders: Prevalence and associated risk factors. Int Urogynecol J 2007;18:397-400.
86. Cathcart P, van der Meulen J, Armitage J, et al. Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England. J Urol 2006;176:200-204.
87. Armitage J, Sibanda N, Cathcart P, et al. Mortality in men admitted to hospital with acute urinary retention: Database analysis. Br Med J 2007;335:1199-202.
88. Omli R, Skotnes L, Mykletun A, et al. Residual urine as a risk factor for lower urinary tract infection: A 1-year follow-up study in nursing homes. J Am Geriatr Soc 2008;56:871-4.
89. Tang MWS, Kwok TCY, Hui E, et al. Intermittent versus indwelling urinary catheterization in older female patients. Maturitas 2006;53:274-81.
90. van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardisation of terminology in nocturia: Report fromthe Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 2002;21:179-83.
91. Chen F, Dai Y, Liu C, et al. Perception of nocturia and medical consulting behaviour among community-dwelling women. Int Urogynecol J 2007;18:431-6.
92. Weatherall M, Slow T,Wiltshire K. Risk factors for entry into residential care after a support-needs assessment. N Z Med J 2004;117:U1075.
93. Tikkinen K, Tammela T, Huhtala H, et al. Is nocturia equally common among men and women? A population based study in Finland. J Urol 2006;175:596-600.
94. Mock L, Parmelee P, Kutner N, et al. Content validation of a symptomspecific Nocturia Quality of Life instrument developed in men: Issues expressed by women as well as men. Urology 2008; 72:736-742.
95. FitzgeraldM, Litman H, Link C, et al. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: Results from the BACH survey. J Urol 2007;177:1385.
96. Johnson TM II, Sattin R, Parmelee P, et al. Evaluating potentially modifiable risk factors for prevalent and incident nocturia in older adults. J Am Geriatr Soc 2005;53:1011-6.
97. Weiss J, Blaivas J, Jones M, et al. Age related pathogenesis of nocturia in patients with overactive bladder. J Urol 2007;178:548.
98. Umlauf MG, Chasens ER, Greevy RA, et al. Obstructive sleep apnea, nocturia and polyuria in older adults. Sleep 2004;27:139-44.
99. Bliwise DL, Adelman CL, Ouslander JG. Polysomnographic correlates of spontaneous nocturnal wetness episodes in incontinent geriatric patients. Sleep 2004;27:153-7.
100. Abraham L, Hareendran A, Mills I, et al. Development and validation of a quality-of-life measure for men with nocturia. Urology 2004;63:481-6.
101. Fitzgerald M, Mulligan M, Parthasarathy S. Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. Am J Obstet Gynecol 2006;194:1399-403.
102. Vaughan C, Endeshaw Y, Nagamia Z, et al. A multicomponent behavioural and drug intervention for nocturia in elderly men: Rationale and pilot results. BJU Int 2009;104:69-74.
103. Johnson TM II, Burgio K, Redden D, et al. Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc 2005;53:846-50.
104. Rackley R, Weiss J, Rovner E, et al. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology 2006;67:731-6.
105. Johnson TM II, Burrows P, Kusek J, et al. Medical Therapy of Prostatic Symptoms Research Group. The effect of doxazosin, finasteride and combination therapy on nocturia inmen with benign prostatic hyperplasia. J Urol 2007;178:2045-50.
106. Drake M, Mills I, Noble J. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. Urology 2004;171:1199-202.
107. Johnson TM II, Miller M, Tang T, et al. Oral ddAVP for nighttime urinary incontinence in characterized nursing home residents: A pilot study. J Am Med Dir Assoc 2006;7:6-11.
108. Rembratt A, Graugaard-Jensen C, Senderovitz T, et al. Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years. Eur J Clin Pharmacol 2004; 60:397.
109. Wetherall M, Arnold T. Nocturia in adults: Draft New Zealand Guidelines for its assessment and management in primary care. N Z Med J 2006; May 19;119(1234):U1976.
110. Rembratt A, Riis A, Norgaard J. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourol Urodyn 2006;25:105-9.
111. Vaizey CJ, Carapeti E, Cahill JA, et al. Prospective comparison of faecal incontinence grading systems. Gut 1999;44:77-80.
112. Wagg A, Mian S, Lowe D, et al. National audit of continence care for older people: Results of a pilot study. J Eval Clin Pract 2005;11:525-32.
113. Nordling J. The aging bladder-A significant but underestimated role in the development of lower urinary tract symptoms. Exp Gerontol 2002;37:991-9.
114. Madersbacher S, Pycha A, Schatzl G, et al. The aging lower urinary tract: A comparative urodynamic study of men and women. Urology 1998;51:206-12.
115. Walter L, Covinsky K. Cancer screening in elderly patients: A framework for individualized decision making. J Am Med Assoc 2001;285:2750-6.